EGFR and cancer: There is a large body of scientific evidence that the epidermal growth factor receptor (EGFR) pathway contributes to a number of processes involved in cancer cell proliferation, survival and invasion rendering it an attractive target for anticancer therapy (Ciardiello and Tortora, 2001).